A number of companies made headlines recently by trying to boost their profits through illegal drug marketing schemes, cheating on their taxes or skimping on safety, according to Peter Rost, former vice president of marketing for Pfizer and author of the book "Whistleblower."
Pfizer was recently fined $430 million for attempting to defraud a government program. Schering Plough paid a $500 million fine for manufacturing violations and $345 million for improper marketing of Claritin, an allergy drug, Rost says. The U.S. tax authority, the Internal Revenue Service, has demanded that drug company GlaxoSmithKline pay $7.8 billion in back taxes, while Merck may be facing $2 billion in back tax payments.
Full article.
No comments:
Post a Comment